View Document Preview and Link Open Document File Size: 1,25 MB Share Result on Facebook
City New Orleans / / / Event Product Recall / Product Issues / / MedicalCondition Natalizumab* Multiple sclerosis / 99m Tc** Diagnostic aid Cardiopulmonary arrest / Bromfenac NSAID Acute liver failure / Terfenadine Antihistamine Torsades de Pointes / Rapacuronium Anesthesia Bronchospasm / Valdecoxib Pain relief Cholesterol lowering Torsades de Pointes / Troglitazone Diabetes / stroke CYP/transporter substrate Skin reactions / constipation / Astemizole Antihistamine Torsades de Pointes / Chronic / stable angina Torsades de Pointes / Grepafloxacin Antibiotics Risk CYP/transporter inhibitor Torsades de Pointes / Drug-drug interactions Heart attack / Drug-drug interactions Acute liver failure Rhabdomyolysis / women Ischemic colitis / Alosetron* Irritable bowel syndrome / Levomethadyl Opiate dependence Fatal arrhythmia / / Organization FDA / office of Planning and Analysis / World Congress / American Association of Pharmaceutical Scientists Annual / office of Clinical Pharmacology / OTS Center for Drug Evaluation and Research / / Product clopidogrel / Drugs / simvastatin / digoxin / Technetium / Pemoline / / Technology pharmacokinetics / / URL http / SocialTag 
The Role of Drug Transporters in Drug Safety-Perspective from the FDA